Hemab ApS

Active
Registration 40837590
APS
Established 27 September, 2019

Relations

Past relations

Ultimate beneficial owners (UBOs): Ole Jakob Müller
2022-03-25 – 2023-02-15

Steen Riisgaard
2020-11-20 – 2023-02-15

Lars Henrik Fugger
2020-11-20 – 2023-02-15

Liselotte Højgaard
2020-11-20 – 2023-02-15

Marianne Philip
2020-11-20 – 2023-02-15

Lars Henrik Munch
2020-11-20 – 2023-02-15

Lars Rebien Sørensen
2020-11-20 – 2023-02-15

Mads Boritz Grøn
2020-11-20 – 2023-02-15

Stig Strøbæk
2022-03-25 – 2023-02-15

Anne Marie Handrup Kverneland
2020-11-20 – 2022-03-25

Lars Bo Køppler
2020-11-20 – 2022-03-25

Johan Henrik Faber
2019-09-27 – 2020-11-20 33.05% ownership (2020-11-25 – 2021-07-22 ) 34% ownership (2019-09-27 – 2020-11-20 ) 33.05% voting rights (2020-11-25 – 2021-07-22 ) 34% voting rights (2019-09-27 – 2020-11-20 )
Legal owners: Ebumab Holding ApS 100% ownership (2019-09-27 – 2020-06-21 ) 90% ownership (2020-06-22 – 2020-11-19 ) 50% ownership (2020-11-20 – 2021-07-21 ) 25% ownership (2021-07-22 – 2022-05-03 ) 20% ownership (2022-05-04 – 2022-12-19 ) 15% ownership (2022-12-20 – 2023-01-13 ) 10% ownership (2023-01-14 – 2023-02-14 ) 5% ownership (2023-02-15 – ) 100% voting rights (2019-09-27 – 2020-06-21 ) 90% voting rights (2020-06-22 – 2020-11-19 ) 50% voting rights (2020-11-20 – 2021-07-21 ) 25% voting rights (2021-07-22 – 2022-05-03 ) 20% voting rights (2022-05-04 – 2022-12-19 ) 15% voting rights (2022-12-20 – 2023-01-13 ) 10% voting rights (2023-01-14 – 2023-02-14 ) 5% voting rights (2023-02-15 – )

RA Capital Nexus Fund II, L.P.
2021-07-22 – 5% ownership (2021-07-22 – ) 5% voting rights (2021-07-22 – )

Novo Holdings A/S 33.33% ownership (2020-11-20 – 2022-05-03 ) 25% ownership (2022-05-04 – 2023-02-14 ) 20% ownership (2023-02-15 – ) 33.33% voting rights (2020-11-20 – 2022-05-03 ) 25% voting rights (2022-05-04 – 2023-02-14 ) 20% voting rights (2023-02-15 – )

DEEP TRACK BIOTECHNOLOGY MASTER FUND, LTD.
2023-02-15 – 5% ownership (2023-02-15 – ) 5% voting rights (2023-02-15 – )

AI DEN-MAB LLC
2023-02-15 – 15% ownership (2023-02-15 – ) 15% voting rights (2023-02-15 – )

AVORO VENTURES FUND L.P.
2023-02-15 – 5% ownership (2023-02-15 – ) 5% voting rights (2023-02-15 – )

Novo Holdings A/S 33.33% ownership (2020-11-20 – 2022-05-03 ) 25% ownership (2022-05-04 – 2023-02-14 ) 20% ownership (2023-02-15 – ) 33.33% voting rights (2020-11-20 – 2022-05-03 ) 25% voting rights (2022-05-04 – 2023-02-14 ) 20% voting rights (2023-02-15 – )

HealthCap VIII L.P.
2022-12-20 – 2023-02-14 10% ownership (2021-07-22 – 2022-05-03 ) 15% ownership (2022-05-04 – 2022-12-19 ) 20% ownership (2022-12-20 – 2023-02-14 ) 10% voting rights (2021-07-22 – 2022-05-03 ) 15% voting rights (2022-05-04 – 2022-12-19 ) 20% voting rights (2022-12-20 – 2023-02-14 )

RA Capital Healthcare Fund, L.P.
2022-12-20 – 2023-02-14 10% ownership (2021-07-22 – 2022-05-03 ) 15% ownership (2022-05-04 – 2022-12-19 ) 20% ownership (2022-12-20 – 2023-02-14 ) 10% voting rights (2021-07-22 – 2022-05-03 ) 15% voting rights (2022-05-04 – 2022-12-19 ) 20% voting rights (2022-12-20 – 2023-02-14 )

Ebumab Holding ApS 100% ownership (2019-09-27 – 2020-06-21 ) 90% ownership (2020-06-22 – 2020-11-19 ) 50% ownership (2020-11-20 – 2021-07-21 ) 25% ownership (2021-07-22 – 2022-05-03 ) 20% ownership (2022-05-04 – 2022-12-19 ) 15% ownership (2022-12-20 – 2023-01-13 ) 10% ownership (2023-01-14 – 2023-02-14 ) 5% ownership (2023-02-15 – ) 100% voting rights (2019-09-27 – 2020-06-21 ) 90% voting rights (2020-06-22 – 2020-11-19 ) 50% voting rights (2020-11-20 – 2021-07-21 ) 25% voting rights (2021-07-22 – 2022-05-03 ) 20% voting rights (2022-05-04 – 2022-12-19 ) 15% voting rights (2022-12-20 – 2023-01-13 ) 10% voting rights (2023-01-14 – 2023-02-14 ) 5% voting rights (2023-02-15 – )

Ebumab Holding ApS 100% ownership (2019-09-27 – 2020-06-21 ) 90% ownership (2020-06-22 – 2020-11-19 ) 50% ownership (2020-11-20 – 2021-07-21 ) 25% ownership (2021-07-22 – 2022-05-03 ) 20% ownership (2022-05-04 – 2022-12-19 ) 15% ownership (2022-12-20 – 2023-01-13 ) 10% ownership (2023-01-14 – 2023-02-14 ) 5% ownership (2023-02-15 – ) 100% voting rights (2019-09-27 – 2020-06-21 ) 90% voting rights (2020-06-22 – 2020-11-19 ) 50% voting rights (2020-11-20 – 2021-07-21 ) 25% voting rights (2021-07-22 – 2022-05-03 ) 20% voting rights (2022-05-04 – 2022-12-19 ) 15% voting rights (2022-12-20 – 2023-01-13 ) 10% voting rights (2023-01-14 – 2023-02-14 ) 5% voting rights (2023-02-15 – )

Ebumab Holding ApS 100% ownership (2019-09-27 – 2020-06-21 ) 90% ownership (2020-06-22 – 2020-11-19 ) 50% ownership (2020-11-20 – 2021-07-21 ) 25% ownership (2021-07-22 – 2022-05-03 ) 20% ownership (2022-05-04 – 2022-12-19 ) 15% ownership (2022-12-20 – 2023-01-13 ) 10% ownership (2023-01-14 – 2023-02-14 ) 5% ownership (2023-02-15 – ) 100% voting rights (2019-09-27 – 2020-06-21 ) 90% voting rights (2020-06-22 – 2020-11-19 ) 50% voting rights (2020-11-20 – 2021-07-21 ) 25% voting rights (2021-07-22 – 2022-05-03 ) 20% voting rights (2022-05-04 – 2022-12-19 ) 15% voting rights (2022-12-20 – 2023-01-13 ) 10% voting rights (2023-01-14 – 2023-02-14 ) 5% voting rights (2023-02-15 – )

HealthCap VIII L.P.
2022-05-04 – 2022-12-19 10% ownership (2021-07-22 – 2022-05-03 ) 15% ownership (2022-05-04 – 2022-12-19 ) 20% ownership (2022-12-20 – 2023-02-14 ) 10% voting rights (2021-07-22 – 2022-05-03 ) 15% voting rights (2022-05-04 – 2022-12-19 ) 20% voting rights (2022-12-20 – 2023-02-14 )

RA Capital Healthcare Fund, L.P.
2022-05-04 – 2022-12-19 10% ownership (2021-07-22 – 2022-05-03 ) 15% ownership (2022-05-04 – 2022-12-19 ) 20% ownership (2022-12-20 – 2023-02-14 ) 10% voting rights (2021-07-22 – 2022-05-03 ) 15% voting rights (2022-05-04 – 2022-12-19 ) 20% voting rights (2022-12-20 – 2023-02-14 )

Novo Holdings A/S 33.33% ownership (2020-11-20 – 2022-05-03 ) 25% ownership (2022-05-04 – 2023-02-14 ) 20% ownership (2023-02-15 – ) 33.33% voting rights (2020-11-20 – 2022-05-03 ) 25% voting rights (2022-05-04 – 2023-02-14 ) 20% voting rights (2023-02-15 – )

Ebumab Holding ApS 100% ownership (2019-09-27 – 2020-06-21 ) 90% ownership (2020-06-22 – 2020-11-19 ) 50% ownership (2020-11-20 – 2021-07-21 ) 25% ownership (2021-07-22 – 2022-05-03 ) 20% ownership (2022-05-04 – 2022-12-19 ) 15% ownership (2022-12-20 – 2023-01-13 ) 10% ownership (2023-01-14 – 2023-02-14 ) 5% ownership (2023-02-15 – ) 100% voting rights (2019-09-27 – 2020-06-21 ) 90% voting rights (2020-06-22 – 2020-11-19 ) 50% voting rights (2020-11-20 – 2021-07-21 ) 25% voting rights (2021-07-22 – 2022-05-03 ) 20% voting rights (2022-05-04 – 2022-12-19 ) 15% voting rights (2022-12-20 – 2023-01-13 ) 10% voting rights (2023-01-14 – 2023-02-14 ) 5% voting rights (2023-02-15 – )

RA Capital Healthcare Fund, L.P.
2021-07-22 – 2022-05-03 10% ownership (2021-07-22 – 2022-05-03 ) 15% ownership (2022-05-04 – 2022-12-19 ) 20% ownership (2022-12-20 – 2023-02-14 ) 10% voting rights (2021-07-22 – 2022-05-03 ) 15% voting rights (2022-05-04 – 2022-12-19 ) 20% voting rights (2022-12-20 – 2023-02-14 )

HealthCap VIII L.P.
2021-07-22 – 2022-05-03 10% ownership (2021-07-22 – 2022-05-03 ) 15% ownership (2022-05-04 – 2022-12-19 ) 20% ownership (2022-12-20 – 2023-02-14 ) 10% voting rights (2021-07-22 – 2022-05-03 ) 15% voting rights (2022-05-04 – 2022-12-19 ) 20% voting rights (2022-12-20 – 2023-02-14 )

Ebumab Holding ApS 100% ownership (2019-09-27 – 2020-06-21 ) 90% ownership (2020-06-22 – 2020-11-19 ) 50% ownership (2020-11-20 – 2021-07-21 ) 25% ownership (2021-07-22 – 2022-05-03 ) 20% ownership (2022-05-04 – 2022-12-19 ) 15% ownership (2022-12-20 – 2023-01-13 ) 10% ownership (2023-01-14 – 2023-02-14 ) 5% ownership (2023-02-15 – ) 100% voting rights (2019-09-27 – 2020-06-21 ) 90% voting rights (2020-06-22 – 2020-11-19 ) 50% voting rights (2020-11-20 – 2021-07-21 ) 25% voting rights (2021-07-22 – 2022-05-03 ) 20% voting rights (2022-05-04 – 2022-12-19 ) 15% voting rights (2022-12-20 – 2023-01-13 ) 10% voting rights (2023-01-14 – 2023-02-14 ) 5% voting rights (2023-02-15 – )

GV1 Holding ApS 5% ownership (2020-06-22 – 2020-11-20 ) 5% voting rights (2020-06-22 – 2020-11-20 )

Ebumab Holding ApS 100% ownership (2019-09-27 – 2020-06-21 ) 90% ownership (2020-06-22 – 2020-11-19 ) 50% ownership (2020-11-20 – 2021-07-21 ) 25% ownership (2021-07-22 – 2022-05-03 ) 20% ownership (2022-05-04 – 2022-12-19 ) 15% ownership (2022-12-20 – 2023-01-13 ) 10% ownership (2023-01-14 – 2023-02-14 ) 5% ownership (2023-02-15 – ) 100% voting rights (2019-09-27 – 2020-06-21 ) 90% voting rights (2020-06-22 – 2020-11-19 ) 50% voting rights (2020-11-20 – 2021-07-21 ) 25% voting rights (2021-07-22 – 2022-05-03 ) 20% voting rights (2022-05-04 – 2022-12-19 ) 15% voting rights (2022-12-20 – 2023-01-13 ) 10% voting rights (2023-01-14 – 2023-02-14 ) 5% voting rights (2023-02-15 – )

Ebumab Holding ApS 100% ownership (2019-09-27 – 2020-06-21 ) 90% ownership (2020-06-22 – 2020-11-19 ) 50% ownership (2020-11-20 – 2021-07-21 ) 25% ownership (2021-07-22 – 2022-05-03 ) 20% ownership (2022-05-04 – 2022-12-19 ) 15% ownership (2022-12-20 – 2023-01-13 ) 10% ownership (2023-01-14 – 2023-02-14 ) 5% ownership (2023-02-15 – ) 100% voting rights (2019-09-27 – 2020-06-21 ) 90% voting rights (2020-06-22 – 2020-11-19 ) 50% voting rights (2020-11-20 – 2021-07-21 ) 25% voting rights (2021-07-22 – 2022-05-03 ) 20% voting rights (2022-05-04 – 2022-12-19 ) 15% voting rights (2022-12-20 – 2023-01-13 ) 10% voting rights (2023-01-14 – 2023-02-14 ) 5% voting rights (2023-02-15 – )
Directors: Benny Sørensen
2022-01-10 –

Mads Nikolaj Behrndt-Eriksen
2021-09-01 –

Johan Henrik Faber
2019-09-27 – 2023-03-01
Board members: Mårten Steen
2021-07-22 –

Akshay Krishnadas Vaishnaw
2024-01-16 –

Uya Chuluunbaatar
2023-02-15 –

Daniel Becker
2023-02-15 –

John Michael Maraganore
2022-01-10 –

Linda Catharina Bain
2022-01-10 –

Laura Anne Tadvalkar
2021-07-22 –

Jørgen Søberg Petersen
2022-01-10 –

Jørgen Søberg Petersen
2020-11-20 – 2022-01-09

Benny Sørensen
2020-11-20 – 2021-07-22

Camilla Petrycer Hansen
2020-11-20 – 2021-07-22

Johan Henrik Faber
2019-09-27 – 2021-07-22

Hans Heugh Wandall
2020-06-22 – 2020-11-20

Søren Erik Bjørn
2020-06-22 – 2020-11-20

Thomas Dal Stenfeldt Batchelor
2019-09-27 – 2020-11-20

Kim Stengaard Holmsted
2019-09-27 – 2020-06-22

Hans Heugh Wandall
2019-09-27 – 2020-06-21

Employees

Hemab ApS has 25.00 full time equivalents (FTEs) and 25.00 employees as of 1 May, 2025.

Hemab ApS

Company information

Relations

Employees